Free tool
FAERS Monitor: Tygacil
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021821 or its brand name (Tygacil, Tigecycline). Reports on generic versions are filed under their own applications.
Reports
6,220
Serious
5,767
93% of reports
Hospitalization
2,498
Death reported
1,654
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective763
- off label use696
- nausea417
- vomiting283
- sepsis270
- thrombocytopenia261
- death258
- septic shock243
- drug resistance225
- coagulopathy216
- diarrhoea213
- condition aggravated205
- pathogen resistance203
- product use in unapproved indication181
- acute kidney injury179
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2005 | 20 |
| 2006 | 76 |
| 2007 | 139 |
| 2008 | 152 |
| 2009 | 175 |
| 2010 | 205 |
| 2011 | 183 |
| 2012 | 159 |
| 2013 | 181 |
| 2014 | 136 |
| 2015 | 215 |
| 2016 | 178 |
| 2017 | 305 |
| 2018 | 329 |
| 2019 | 525 |
| 2020 | 445 |
| 2021 | 473 |
| 2022 | 402 |
| 2023 | 505 |
| 2024 | 598 |
| 2025 | 486 |
| 2026 | 333 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,939 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| pathogen resistanceSignal | 203 | 77.0 | 67.2 | 14,821 |
| coagulopathySignal | 216 | 44.4 | 38.9 | 9,008 |
| drug resistanceSignal | 225 | 29.9 | 26.3 | 6,203 |
| septic shockSignal | 243 | 19.0 | 16.8 | 4,108 |
| sepsisSignal | 270 | 8.2 | 7.3 | 1,705 |
| thrombocytopeniaSignal | 261 | 7.9 | 7.0 | 1,573 |
| acute kidney injurySignal | 179 | 4.0 | 3.4 | 395 |
| off label useSignal | 696 | 2.7 | 2.5 | 768 |
| product use in unapproved indicationSignal | 181 | 2.5 | 2.1 | 159 |
| condition aggravatedSignal | 205 | 2.3 | 2.0 | 148 |
| vomitingSignal | 283 | 2.0 | 1.8 | 151 |
| drug ineffective | 763 | 2.0 | 1.8 | 380 |
| nausea | 417 | 1.8 | 1.6 | 148 |
| diarrhoea | 213 | 1.1 | 1.0 | 3 |
| death | 258 | 1.0 | 0.9 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.